开放期刊系统

MicroRNA 在变应性鼻炎中的研究进展

子 徐(承德医学院附属医院,中国)
祎(承德医学院附属医院,中国)

摘要

变应性鼻炎(Allergic rhinitis,AR)是免疫球蛋白E(immunoglobulin E,IgE)介导的鼻部相关的非感染性慢性炎性疾病,主要表现为阵发性喷嚏、流清涕、鼻塞,可导致睡眠障碍、注意力下降、疲劳甚至是抑郁,从不同程度上影响人们的生活质量和工作效率,目前对于AR的治疗已取得极大进展,但仍有部分患者的症状未得到足够改善。因此,有必要更加深入研究AR发病机制从而进一步提升AR的诊疗水平。MicroRNA(miRNA)是一类短单链非编码RNA,通过结合靶信使RNA(mRNA)上的3’-末端翻译位点诱导RNA降解或阻断蛋白质合成,可以调节转录后基因的表达,被认为与许多炎性疾病、血管疾病、癌症等相关,是众多国内外学者的研究重点。论文与AR密切相关的miRNA研究进展作一简述,希望可以对AR诊断与治疗方面的研究进展提供帮助。

关键词

变应性鼻炎;miRNA;诊断治疗

全文:

PDF

参考

张芳,刘海,张建辉.外泌体在变应性鼻炎中的研究进展[J].医学研究与战创伤救治,2023,36(2):209-213.

Jingyan H, Songli H, Xiaoli L, et al. miR-155: An Important Role in Inflammation Response[J]. Journal of Immunology Research,2022,20227437281-7437281.

M N H, Fedaa N, M E E, et al. Role of MicroRNA-155 as a Potential Biomarker for Allergic Rhinitis in Children[J]. Canadian respiratory journal,2021,20215554461-5554461.

Li Y, An R, Wu M, et al. miR-224-5p Attenuates Allergic Responses in Mice with Allergic Rhinitis by Modulating the Th1/Th2 Response[J]. Analytical cellular pathology (Amsterdam),2024,20245531970-5531970.

姜辉,王嘉玺,刘大新,等.MicroRNA与变应性鼻炎关系的研究进展[J].医学综述,2021,27(15):2952-2956.

Lu S, Kong H, Hou Y, et al. Two Plasma MicroRNA Panels for Diagnosis and Subtype Discrimination of Lung Cancer[J]. Lung Cancer,2018,12344-12351.

曾祥英,秦晨光,聂国明.武汉市4~14岁儿童过敏性鼻炎的危险因素分析[J].中国儿童保健杂志,2018,26(5):551-554.

姚红斌,鲁建凤.舌下含服粉尘螨滴剂治疗儿童变应性鼻炎的长期疗效及安全性观察[J].临床耳鼻咽喉头颈外科杂志,2017,31(5):377-381.

Tao L, Ha M L, Bruce H, et al. MicroRNA-21 as a potential colon and rectal cancer biomarker[J]. World journal of gastroenterology,2013,19(34):5615-5621.

杨志强,陈小婉,张小兵.Micro-RNA在变应性鼻炎中的作用及其研究进展[J].中国耳鼻咽喉颅底外科杂志,2023,29(1):123-128.

Shaoqing Y, Ruxin Z, Guojun L, et al. Microarray Analysis of Differentially Expressed microRNAs in Allergic Rhinitis[J]. American Journal of Rhinology & Allergy,2011,25(6):e242-e246.

Hille S, Elina T, Maritta K, et al. MicroRNA profiles in nasal mucosa of patients with allergic and nonallergic rhinitis and asthma[J]. International forum of allergy & rhinology,2013,3(8):612-620.

Lin M, Kunmei L, Meijuan X, et al. miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling[J]. Cancer immunology, immunotherapy: CII,2014,63(7):699-711.

Jing Y, Hao W, Zi-Yu L, et al. Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation[J]. International journal of molecular medicine,2017,40(4):1185-1193.

Wang T, Chen D, Wang P, et al. miR-375 prevents nasal mucosa cells from apoptosis and ameliorates allergic rhinitis via inhibiting JAK2/STAT3 pathway[J]. Biomedicine & Pharmacotherapy,2018,103621-10627.

Wang T, Chen D, Wang P, et al. miR-375 prevents nasal mucosa cells from apoptosis and ameliorates allergic rhinitis via inhibiting JAK2/STAT3 pathway[J]. Biomedicine & Pharmacotherapy,2018,103621-10627.

Xiaoyuan Z, Xueping W, Ying W, et al. The regulatory network among CircHIPK3, LncGAS5, and miR-495 promotes Th2 differentiation in allergic rhinitis[J]. Cell death & disease, 2020,11(4):216.

Xiaoyuan Z, Xueping W, Ying W, et al. The regulatory network among CircHIPK3, LncGAS5, and miR-495 promotes Th2 differentiation in allergic rhinitis[J]. Cell death & disease,2020,11(4):216.

Z C, Y D, F L, et al. MicroRNA-466a-3p attenuates allergic nasal inflammation in mice by targeting GATA3[J]. Clinical and experimental immunology,2019,197(3):366-375.

S. Cho, C. J. Wu, T. Yasuda et al. miR-23-27-24 clusters control effector T cell differentiation and function[J]. Journal of Experimental Medicine, 2013(2):235-249.

Li Y, An R, Wu M, et al. miR-224-5p Attenuates Allergic Responses in Mice with Allergic Rhinitis by Modulating the Th1/Th2 Response[J]. Analytical cellular pathology (Amsterdam),2024,20245531970-5531970.

Ismail O, Yagiz P, Ozge A, et al. Advances and highlights in biomarkers of allergic diseases[J].Allergy,2021,76(12):3659-3686.



DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i7.19719

Refbacks

  • 当前没有refback。
版权所有(c)2024 子 徐, 祎 Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。
  • :+65-62233778 QQ:2249355960 :contact@s-p.sg